Star Pharmaceutical Limited operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Star Pharmaceutical Limited with three other
pharmaceutical manufacturers in Asia:
Mezzion Pharma Co Ltd
of South Korea
sales of 8.75 billion Korean Won [US$7.83 million]
(1.07 billion Japanese Yen [US$9.58 million]
of which 94%
was iPS cell business), and
Natural Capsules Limited
based in India
(620.53 million Indian Rupees [US$9.48 million]
During the year ended December of 2016, sales at
Star Pharmaceutical Limited were 61.68 million Chinese Renmimbi (US$8.96 million).
decrease of 31.6%
versus 2015, when the company's sales were 90.19 million Chinese Renmimbi.